FDA Launches Investigation into Yaz and Other Birth Control Drugs Containing Drosperinone
The Food and Drug Administration has issued a warning to all users of Yaz, Yasmin, Ocella, Beyaz, and Safyral: if you develop shortness of breath, leg pain and/or chest pain, you could be suffering from blood clots or other complications linked to these drugs, and you should seek immediate medical attention.
This warning is on the heels of the FDA’s announcement that it is investigating the unusually high risk of blood clots that has been associated with these drugs. Promising to communicate any new safety information that is uncovered in its investigation, the FDA also recommended that women currently taking these drugs continue to do so and that they take all questions to their prescribing physician.
Wexler Wallace represents women from across the United States that have been injured by Yaz, Yasmin, Ocella, Beyaz, and Safyral. These plaintiffs are pursuing lawsuits for injuries that include: gall bladder failure and removal, strokes, heart attacks, blood clots, DVTs, pulmonary embolisms and even death. To contact the firm about investigating your claim, please click here.